AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33722363 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐hrClass
Number of subjects: 0
Study 33722363 — intervention group
Group type: EXPERIMENTAL
Intervention: 20‐minVideo
Number of subjects: 0
Study 33722363 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 34643128 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy checkout lane intervention (moving peanuts to cash registers and upselling)
Number of subjects: 6
Study 34643128 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no intervention)
Number of subjects: 6
Study 34643128 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy checkout lane intervention with price promotion
Number of subjects: 6
Study 35292493 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Stroke Specialist Vocational Rehabilitation (ESSVR) plus usual care
Number of subjects: 0
Study 35292493 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 0
Study 35879008 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist palliative home care nurse-patient consultation followed by an interprofessional telephone case conference
Number of subjects: 191
Study 35879008 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 191
Study 32464142 — intervention group
Group type: EXPERIMENTAL
Intervention: Etrolizumab
Number of subjects: 535
Study 32464142 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 535
Study 32966563 — intervention group
Group type: COMPARATOR
Intervention: Control condition (natural loading)
Number of subjects: 30
Study 32966563 — intervention group
Group type: EXPERIMENTAL
Intervention: High loading (5% increase in vGRF)
Number of subjects: 30
Study 32966563 — intervention group
Group type: EXPERIMENTAL
Intervention: Symmetric loading (vGRF between limbs)
Number of subjects: 30
Study 35438588 — intervention group
Group type: EXPERIMENTAL
Intervention: Patella-stabilizing, motion-restricting knee brace
Number of subjects: 79
Study 35438588 — intervention group
Group type: COMPARATOR
Intervention: Neoprene nonhinged knee brace
Number of subjects: 79
Study 34610615 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwifery-oriented group counseling based on the GATHER approach (4 sessions of 45 to 90 minutes)
Number of subjects: 90
Study 34610615 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 90
Study 34610615 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwifery-oriented group counseling based on the GATHER approach
Number of subjects: 90
Study 34927036 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis spp. lactis (Bl‐04)
Number of subjects: 334
Study 34927036 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 334
Study 33009977 — intervention group
Group type: EXPERIMENTAL
Intervention: Elemental diet (ELENTAL®) 160 g/day for 9 weeks during chemotherapy
Number of subjects: 71
Study 33009977 — intervention group
Group type: COMPARATOR
Intervention: Non-supplementary group (no elemental diet)
Number of subjects: 71
Study 35074539 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative mobilization program
Number of subjects: 150
Study 35074539 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative mobilization program)
Number of subjects: 150
Study 32631405 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A 25,000 IU daily, Vitamin D 600,000 IU once, Vitamin E 300 IU twice daily, Vitamin C four times per day, B vitamins daily (Soluvit)
Number of subjects: 60
Study 32631405 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplements or placebo)
Number of subjects: 60
Study 33593788 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care viral load testing
Number of subjects: 100
Study 33593788 — intervention group
Group type: COMPARATOR
Intervention: Standard laboratory viral load monitoring
Number of subjects: 100
Study 33275112 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual abstract tweets
Number of subjects: 40
Study 33275112 — intervention group
Group type: COMPARATOR
Intervention: Citation-only tweets
Number of subjects: 40
Study 33275112 — intervention group
Group type: COMPARATOR
Intervention: Key figure tweets
Number of subjects: 40
Study 33820701 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI) at 13-14 °C for a total of 170 minutes
Number of subjects: 0
Study 33820701 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI)
Number of subjects: 0
Study 32100495 — intervention group
Group type: EXPERIMENTAL
Intervention: Suspension moxibustion combined with hormone therapy
Number of subjects: 132
Study 32100495 — intervention group
Group type: COMPARATOR
Intervention: Moxibustion
Number of subjects: 132
Study 32100495 — intervention group
Group type: COMPARATOR
Intervention: Hormone without moxibustion
Number of subjects: 132
Study 32100495 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone with moxibustion
Number of subjects: 132
Study 34687130 — intervention group
Group type: EXPERIMENTAL
Intervention: Nucleotide/nucleoside analogues (NAs)
Number of subjects: 2172
Study 34687130 — intervention group
Group type: EXPERIMENTAL
Intervention: High M6-GGT levels (>25 U/L)
Number of subjects: 2172
Study 34687130 — intervention group
Group type: EXPERIMENTAL
Intervention: Cirrhosis
Number of subjects: 2172
Study 34687130 — intervention group
Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 2172
Study 34687130 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 2172
Study 34687130 — intervention group
Group type: EXPERIMENTAL
Intervention: High M6-GGT levels (>25 U/L) in non-cirrhotic patients
Number of subjects: 2172
Study 34687130 — intervention group
Group type: EXPERIMENTAL
Intervention: High M6-GGT levels in non-cirrhotic patients
Number of subjects: 2172
Study 34687130 — intervention group
Group type: EXPERIMENTAL
Intervention: Age in non-cirrhotic patients
Number of subjects: 2172
Study 34687130 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-cirrhotic elderly patients with high M6-GGT levels
Number of subjects: 2172
Study 33631078 — intervention group
Group type: EXPERIMENTAL
Intervention: Zagreb regimen
Number of subjects: 240
Study 33631078 — intervention group
Group type: COMPARATOR
Intervention: Essen regimen
Number of subjects: 240
Study 32572614 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration group (n=185)
Number of subjects: 351
Study 32572614 — intervention group
Group type: COMPARATOR
Intervention: Validation group (n=166)
Number of subjects: 351
Study 35487727 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg alirocumab subcutaneously every 2 weeks for a total of 26 weeks
Number of subjects: 66
Study 35487727 — intervention group
Group type: COMPARATOR
Intervention: Control group (no alirocumab treatment)
Number of subjects: 66
Study 33851221 — intervention group
Group type: COMPARATOR
Intervention: Folic Acid (FA) supplementation
Number of subjects: 1198
Study 35911661 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal Radial Access (DRA)
Number of subjects: 209
Study 35911661 — intervention group
Group type: COMPARATOR
Intervention: Forearm Radial Access (FRA)
Number of subjects: 209
Study 35081022 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose convalescent plasma (CCP) transfusion (3 daily doses of 600 mL/d)
Number of subjects: 107
Study 35081022 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 107
Study 35081022 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose convalescent plasma (CCP) transfusion
Number of subjects: 107
Study 33237632 — intervention group
Group type: EXPERIMENTAL
Intervention: POG patients with WGTA-informed treatment change
Number of subjects: 230
Study 33237632 — intervention group
Group type: COMPARATOR
Intervention: POG-naive controls
Number of subjects: 230
Study 32285460 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of Perineural invasion (PNI)
Number of subjects: 976
Study 35436907 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based training program
Number of subjects: 120
Study 35436907 — intervention group
Group type: COMPARATOR
Intervention: Usual individual physiotherapy care
Number of subjects: 120
Study 33764385 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment (molecular inhibitor)
Number of subjects: 298
Study 33764385 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment (cytotoxic therapy)
Number of subjects: 298
Study 33764385 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment (hormone therapy)
Number of subjects: 298
Study 33764385 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment (immune therapy)
Number of subjects: 298
Study 33764385 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary end point (PFS)
Number of subjects: 298
Study 33764385 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall RCTs
Number of subjects: 298
Study 33764385 — intervention group
Group type: EXPERIMENTAL
Intervention: Reports using a professional medical writer
Number of subjects: 298
Study 35727083 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine (0.5 mg/kg parenteral dose)
Number of subjects: 15
Study 34949171 — intervention group
Group type: EXPERIMENTAL
Intervention: Proud & Empowered intervention
Number of subjects: 0
Study 34949171 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 34229074 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous morphine intravenous infusion
Number of subjects: 20
Study 34229074 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous morphine + naloxone infusion
Number of subjects: 20
Study 34229074 — intervention group
Group type: COMPARATOR
Intervention: Placebo intravenous infusion
Number of subjects: 20
Study 34229074 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold‐pressor test (1-4Hz EEG)
Number of subjects: 20
Study 34229074 — intervention group
Group type: EXPERIMENTAL
Intervention: Faster EEG (8-12Hz) during cold‐pressor test
Number of subjects: 20
Study 32385061 — intervention group
Group type: EXPERIMENTAL
Intervention: PIFR-based optimised inhalation therapy and training on inhaler usage at discharge
Number of subjects: 416
Study 32385061 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving inhalers based on judgement of the respiratory physician
Number of subjects: 416
Study 35323052 — intervention group
Group type: EXPERIMENTAL
Intervention: LAMA + LABA (Stiolto Respimat)
Number of subjects: 14
Study 35323052 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 35637984 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency ablation
Number of subjects: 50
Study 35637984 — intervention group
Group type: COMPARATOR
Intervention: Monopolar radiofrequency ablation
Number of subjects: 50
Study 32584698 — intervention group
Group type: EXPERIMENTAL
Intervention: TTM at 33°C (TTM33)
Number of subjects: 151
Study 32584698 — intervention group
Group type: COMPARATOR
Intervention: TTM at 36°C (TTM36)
Number of subjects: 151
Study 32584698 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature reduction
Number of subjects: 151
Study 33742764 — intervention group
Group type: EXPERIMENTAL
Intervention: RO6870868 (200–2000 mg)
Number of subjects: 60
Study 32113916 — intervention group
Group type: COMPARATOR
Intervention: Atazanavir with a glass of water
Number of subjects: 5
Study 32113916 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir with Coca-Cola®
Number of subjects: 5
Study 32113916 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir with water under hypochlorhydric conditions (PPI)
Number of subjects: 5
Study 35050723 — intervention group
Group type: EXPERIMENTAL
Intervention: Read, Ask, Answer, Prompt (RAAP) intervention taught via telepractice during an initial 60‐min workshop and five advanced practice sessions (M = 28.41 min).
Number of subjects: 5
Study 35050723 — intervention group
Group type: EXPERIMENTAL
Intervention: Read, Ask, Answer, Prompt (RAAP) intervention
Number of subjects: 5
Study 33393666 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow Band Imaging (NBI) during flexible endoscopy
Number of subjects: 233
Study 33393666 — intervention group
Group type: COMPARATOR
Intervention: White Light Imaging (WLI) during rigid endoscopy
Number of subjects: 233
Study 33393666 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow Band Imaging (NBI)
Number of subjects: 233
Study 35673907 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) + chemotherapy
Number of subjects: 94
Study 35673907 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 94
Study 33556546 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation
Number of subjects: 8296
Study 32942192 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact intervention for parents with supervised contact, involving increased preparation and support by caseworkers before and after contact visits
Number of subjects: 183
Study 32942192 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact intervention for parents with supervised contact
Number of subjects: 183
Study 32942192 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 183
Study 33400943 — intervention group
Group type: EXPERIMENTAL
Intervention: LY03004
Number of subjects: 100
Study 33400943 — intervention group
Group type: COMPARATOR
Intervention: Risperdal Consta®
Number of subjects: 100
Study 32058431 — intervention group
Group type: EXPERIMENTAL
Intervention: High-definition transcranial direct current stimulation
Number of subjects: 36
Study 32058431 — intervention group
Group type: COMPARATOR
Intervention: Bipolar transcranial direct current stimulation
Number of subjects: 36
Study 33551142 — intervention group
Group type: EXPERIMENTAL
Intervention: Flapless implant placement with immediate functional loading
Number of subjects: 51
Study 33551142 — intervention group
Group type: COMPARATOR
Intervention: Flap implant placement with immediate functional loading
Number of subjects: 51
Study 33960514 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually randomized trials
Number of subjects: 0
Study 33960514 — intervention group
Group type: COMPARATOR
Intervention: Cluster randomized designs
Number of subjects: 0
Study 32152738 — intervention group
Group type: EXPERIMENTAL
Intervention: GA+ AB (group receiving ankle block with 100mg lidocaine 2% and 75mg bupivacaine 0.5%)
Number of subjects: 110
Study 32152738 — intervention group
Group type: COMPARATOR
Intervention: GA (control group)
Number of subjects: 110
Study 32152738 — intervention group
Group type: EXPERIMENTAL
Intervention: GA+ AB
Number of subjects: 110
Study 35446296 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavioral therapy (TF-CBT) for 14 weeks with 2 weeks follow-up
Number of subjects: 74
Study 35446296 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 74
Study 36269661 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Hyaluronate plus Polyethylene Glycol (0.15% SH + PEG 8000)
Number of subjects: 83
Study 36269661 — intervention group
Group type: COMPARATOR
Intervention: Sodium Hyaluronate (0.18% SH)
Number of subjects: 83
Study 32253054 — intervention group
Group type: EXPERIMENTAL
Intervention: BGF MDI 320/36/9.6 μg without spacer and no charcoal
Number of subjects: 56
Study 32253054 — intervention group
Group type: EXPERIMENTAL
Intervention: BGF MDI 320/36/9.6 μg with spacer and no charcoal
Number of subjects: 56
Study 32253054 — intervention group
Group type: EXPERIMENTAL
Intervention: BGF MDI 320/36/9.6 μg without spacer and with charcoal
Number of subjects: 56
Study 32253054 — intervention group
Group type: EXPERIMENTAL
Intervention: BGF MDI 320/36/9.6 μg with spacer and with charcoal
Number of subjects: 56
Study 32253054 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 56
Study 35841003 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional fasciotomy
Number of subjects: 0
Study 35841003 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral fasciotomy
Number of subjects: 0
Study 35841003 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-reported outcomes at 3 months post-surgery
Number of subjects: 0
Study 34613402 — intervention group
Group type: EXPERIMENTAL
Intervention: 4F antithrombotic midline catheter (MC-AT)
Number of subjects: 212
Study 34613402 — intervention group
Group type: COMPARATOR
Intervention: 4.5F antithrombotic and antimicrobial midline catheter (MC-AT-AM)
Number of subjects: 212
Study 32956481 — intervention group
Group type: EXPERIMENTAL
Intervention: Superior rectus transposition with or without medial rectus recession
Number of subjects: 20
Study 32956481 — intervention group
Group type: COMPARATOR
Intervention: Unilateral medial rectus recession
Number of subjects: 20
Study 34579074 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized mixed meal (498 kcal)
Number of subjects: 14
Study 34579074 — intervention group
Group type: EXPERIMENTAL
Intervention: Granola bar (260 kcal)
Number of subjects: 14
Study 32377523 — intervention group
Group type: EXPERIMENTAL
Intervention: No carrageenan diet (n=8)
Number of subjects: 13
Study 32377523 — intervention group
Group type: COMPARATOR
Intervention: Carrageenan-containing diet (n=5)
Number of subjects: 13
Study 32377523 — intervention group
Group type: COMPARATOR
Intervention: Comparison between no-carrageenan and carrageenan-containing diet groups
Number of subjects: 13
Study 33727090 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week RiSE intervention
Number of subjects: 74
Study 34296980 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulatory skills emphasis (n = 47)
Number of subjects: 99
Study 34296980 — intervention group
Group type: COMPARATOR
Intervention: Education and self-management (n = 52)
Number of subjects: 99
Study 34711975 — intervention group
Group type: EXPERIMENTAL
Intervention: Undisclosed self-administration of suboptimal ART
Number of subjects: 2
Study 34711975 — intervention group
Group type: COMPARATOR
Intervention: None (control group)
Number of subjects: 2
Study 35448022 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Training Group (VRTG) underwent VR training with BTs‐N
Number of subjects: 100
Study 35448022 — intervention group
Group type: COMPARATOR
Intervention: Traditional Cognitive Rehabilitation Group (TCRG) received standard cognitive treatment
Number of subjects: 100
Study 33128925 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal conditions (NC, 20 °C, RH 60%)
Number of subjects: 11
Study 33128925 — intervention group
Group type: COMPARATOR
Intervention: Cold-dry conditions (CC, −20 °C, RH 40%)
Number of subjects: 11
Study 35145044 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention
Number of subjects: 99
Study 33811854 — intervention group
Group type: EXPERIMENTAL
Intervention: VETPALS (N=71)
Number of subjects: 147
Study 33811854 — intervention group
Group type: COMPARATOR
Intervention: Education control (N=76)
Number of subjects: 147
Study 32608341 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Dot (GD) bystander intervention training program targeting popular opinion leaders
Number of subjects: 13
Study 32608341 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Dot (GD) participants
Number of subjects: 13
Study 32608341 — intervention group
Group type: COMPARATOR
Intervention: Nonparticipants of Green Dot (GD)
Number of subjects: 13
Study 32967467 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaze Training (GT)
Number of subjects: 17
Study 32654588 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (14-weeks, four lessons per week)
Number of subjects: 891
Study 32654588 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively engaging exercise (14-weeks, four lessons per week)
Number of subjects: 891
Study 32654588 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular physical education programme)
Number of subjects: 891
Study 37384576 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 52
Study 37384576 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 33593749 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofogliflozin 20 mg, orally, once daily for 24 weeks
Number of subjects: 40
Study 33593749 — intervention group
Group type: COMPARATOR
Intervention: Pioglitazone 15-30 mg, orally, once daily for 24 weeks
Number of subjects: 40
Study 32508277 — intervention group
Group type: EXPERIMENTAL
Intervention: Worry Less, Live More: The Mindful Way through Anxiety Workbook
Number of subjects: 64
Study 32508277 — intervention group
Group type: COMPARATOR
Intervention: Delayed condition
Number of subjects: 64
Study 35667714 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigational agents (up to four agents)
Number of subjects: 125
Study 35667714 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 125
Study 32222958 — intervention group
Group type: EXPERIMENTAL
Intervention: End-to-End (ETE) anastomosis
Number of subjects: 425
Study 32222958 — intervention group
Group type: COMPARATOR
Intervention: End-to-Side (ETS) anastomosis
Number of subjects: 425
Study 34035108 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke 1-2-0 education programme
Number of subjects: 3200000
Study 34035108 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3200000
Study 35552930 — intervention group
Group type: EXPERIMENTAL
Intervention: Axillary lymph node dissection (ALND)
Number of subjects: 889
Study 35552930 — intervention group
Group type: COMPARATOR
Intervention: Sentinel lymph node biopsy (SLNB) only
Number of subjects: 889
Study 34555952 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive nursing interventions
Number of subjects: 85
Study 34269164 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 102
Study 34269164 — intervention group
Group type: COMPARATOR
Intervention: Usual dietary advice
Number of subjects: 102
Study 34516760 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Resilience Training (MBRT)
Number of subjects: 61
Study 34516760 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 61
Study 34579097 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie restriction (CR)
Number of subjects: 46
Study 34579097 — intervention group
Group type: EXPERIMENTAL
Intervention: CR plus Rope-skipping (CR?RS)
Number of subjects: 46
Study 32165027 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine xenograft dressing
Number of subjects: 58
Study 32165027 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver foam dressing
Number of subjects: 58